What is it about?
Chronic rhinosinusitis (CRS) is a long-term condition characterised by nasal blockage, smell loss, a runny nose and facial pain/pressure as well as poor quality of life. The mainstay of treatment is through the use of nasal sprays and rinses. This study of a national database looks at patient reported use of these medications.
Featured Image
Photo by ahmad gunnaivi on Unsplash
Why is it important?
Compliance with treatment is important for disease control and patients are expected to be referred to secondary care from primary care when baseline medical treatment has failed.
Perspectives
Many patients arrive in my clinic without being on baseline treatment for CRS, but this data from 30 centres shows that this is a widespread problem with a number of mitigating factors.
Professor Carl Philpott
University of East Anglia
Read the Original
This page is a summary of: Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study (CRES), Clinical Otolaryngology, December 2017, Wiley,
DOI: 10.1111/coa.13012.
You can read the full text:
Resources
Contributors
The following have contributed to this page
